Dermatology Devices Market

The dermatology devices market is expected to reach USD 17.73 billion by 2031 from USD 9.32 billion in 2026, at a CAGR of 13.7%. The demand for advanced dermatology devices is rising due to the growing prevalence of skin disorders, including skin cancer, acne, psoriasis, and pigmentation disorders, as well as the expanding global demand for aesthetic procedures. Early, accurate diagnosis, paired with effective minimally invasive treatment options, is increasingly important for improving clinical outcomes and patient satisfaction. Ongoing technological advances in laser, radiofrequency (RF), high-intensity focused ultrasound (HIFU), light-based, and imaging technologies are driving the adoption of more precise, efficient, and safer dermatology procedures. Additionally, increasing investments in research and development, expanding dermatology and aesthetic care infrastructure, and rising consumer awareness of skin health and cosmetic treatments are expected to accelerate the development and adoption of advanced dermatology devices in the coming years.

In January 2024, Cynosure (US) and Lutronic (US) entered into a merger agreement to form a leading global medical aesthetics technology company. The strategic combination was intended to expand the companies' product portfolios, strengthen research and development capabilities, broaden their global market presence, and enhance services for healthcare providers and patients.

To know about the assumptions considered for the study download the pdf brochure

In April 2025, Bausch Health Companies Inc. (Canada) launched the Fraxel FTX fractional laser system for skin resurfacing. The system features dual wavelengths (1550 nm and 1927 nm), integrated cooling, ergonomic enhancements, and Intelligent Optical Tracking technology to improve treatment of wrinkles, pigmentation, acne scars, sun damage, and other skin rejuvenation indications, while enhancing procedural precision and the patient experience.

The key players in this market include Bausch Health Companies Inc. (Canada), Sisram Medical Ltd. (Israel), Lumenis Be Ltd. (Israel), InMode Ltd. (Israel), El.En. S.p.A. (Italy), AbbVie Inc. (US), BTL Group of Companies (Czech Republic), Cutera, Inc. (US), Cynosure Lutronic (US), and Candela Corporation (US). Market participants have pursued a range of strategies to strengthen their market position, including advanced product development, partnerships, expansions, and acquisitions. These organic and inorganic strategies have enabled market participants to expand their reach across geographies by offering advanced dermatology solutions.

Bausch Health Companies Inc. (Canada) is a leading pharmaceutical and medical device company with a strong global presence in the dermatology devices market through its Solta Medical business segment. The company offers a broad portfolio of energy-based aesthetic devices for skin resurfacing, skin rejuvenation, body contouring, and scar treatment. Bausch Health is focused on strengthening its dermatology device portfolio through continuous product innovation and technological advancements. In April 2025, the company launched the Fraxel FTX fractional laser system, a next-generation laser platform featuring dual wavelengths (1550 nm and 1927 nm), integrated cooling, ergonomic enhancements, and Intelligent Optical Tracking technology to improve treatment of wrinkles, pigmentation, acne scars, sun damage, and other skin rejuvenation indications. The company's strong global presence, established distribution network, and continued investment in aesthetic technologies further reinforce its position in the dermatology devices market.

Sisram Medical Ltd. (Israel) is a leading provider of medical aesthetics technologies and a key player in the global dermatology devices market. The company offers a comprehensive portfolio of Alma-branded energy-based platforms for applications such as skin rejuvenation, hair removal, body contouring, skin resurfacing, vascular and pigmented lesion treatment, tattoo removal, and acne scar management. Sisram Medical is committed to strengthening its position through continuous product innovation, technological advancements, and expansion of its global distribution network. Its advanced energy-based technologies are widely adopted by dermatologists, plastic surgeons, and aesthetic practitioners worldwide. The company's broad product portfolio, strong international presence, and continued investment in research and development further reinforce its competitive position in the global dermatology devices market.

Market Ranking

Bausch Health Companies Inc. (Canada) has emerged as a leading player in the dermatology devices market through its comprehensive portfolio of energy-based aesthetic technologies and a strong presence in skin resurfacing and body contouring. Sisram Medical Ltd. (Israel) is also a significant participant, leveraging its Alma-branded energy-based platforms and a broad portfolio of solutions for skin rejuvenation, hair removal, body contouring, and vascular treatments. Lumenis Be Ltd. (Israel) has secured a prominent position in the dermatology devices market by offering an extensive range of laser- and intense pulsed light (IPL)-based systems for medical and aesthetic dermatology applications. InMode Ltd. (Israel) plays an important role in the market due to its expertise in minimally invasive and non-invasive radiofrequency-based technologies, supported by continuous product innovation and expanding global adoption. Additionally, El.En. S.p.A. (Italy) maintains a strong position in the dermatology devices market through its advanced laser technologies, a diverse portfolio for medical and aesthetic dermatology applications, and ongoing investments in research and development.

Related Reports:

Dermatology Devices Market by Type (Diagnostic (Dermatoscopes, Microscopes), Treatment (Laser, Cryotherapy), Application (Diagnostic, Medical Therapeutic, Aesthetic Therapeutic), Technology (Light), End User (Hospitals), Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]